1. Home
  2. VICR vs HALO Comparison

VICR vs HALO Comparison

Compare VICR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vicor Corporation

VICR

Vicor Corporation

HOLD

Current Price

$334.08

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$67.87

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VICR
HALO
Founded
1981
1998
Country
United States
United States
Employees
N/A
423
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.1B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
VICR
HALO
Price
$334.08
$67.87
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$217.50
$78.64
AVG Volume (30 Days)
670.3K
1.5M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
1764.29
N/A
EPS
0.44
1.22
Revenue
$452,701,000.00
$151,862,000.00
Revenue This Year
$37.01
$28.24
Revenue Next Year
$39.47
$12.56
P/E Ratio
$737.76
$56.02
Revenue Growth
26.08
N/A
52 Week Low
$41.76
$51.06
52 Week High
$361.89
$82.22

Technical Indicators

Market Signals
Indicator
VICR
HALO
Relative Strength Index (RSI) 61.14 46.56
Support Level $140.71 $66.31
Resistance Level $361.89 $70.54
Average True Range (ATR) 23.22 2.34
MACD 0.58 -0.28
Stochastic Oscillator 87.66 35.18

Price Performance

Historical Comparison
VICR
HALO

About VICR Vicor Corporation

Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: